Filing metadata

Accession number
0000950170-24-069279
Form type
Form 3
Filer
Monte Rosa Therapeutics, Inc.
CIK
CIK 1826457
Filed
Jun 05, 2024
Reporting period
May 28, 2024
Description
Initial ownership

Explore SEC Filings Hub